{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:01:14Z","timestamp":1789984874281,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Tianjin Health Research Project","award":["TJWJ2024ZD008"],"award-info":[{"award-number":["TJWJ2024ZD008"]}]},{"name":"Tianjin Key Medical Discipline Construction Project","award":["TJYXZDXK-3-029C"],"award-info":[{"award-number":["TJYXZDXK-3-029C"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04723-8","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:10:53Z","timestamp":1789981853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KRAS-mutated endometrial carcinomas: a comprehensive analysis of clinicopathological and molecular profiles across histological subtypes"],"prefix":"10.1007","author":[{"given":"Wen-Qi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Xia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wen","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Jie","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"4723_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1309\/ajcp69rbnuhhojri","volume":"143","author":"M He","year":"2015","unstructured":"He M, Jackson CL, Gubrod RB et al (2015) KRAS Mutations in Mucinous Lesions of the Uterus. Am J Clin Pathol 143:778\u2013784. https:\/\/doi.org\/10.1309\/ajcp69rbnuhhojri","journal-title":"Am J Clin Pathol"},{"key":"4723_CR2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/modpathol.2013.186","volume":"27","author":"A Alomari","year":"2014","unstructured":"Alomari A, Abi-Raad R, Buza N et al (2014) Frequent KRAS mutation in complex mucinous epithelial lesions of the endometrium. Mod Pathol 27:675\u2013680. https:\/\/doi.org\/10.1038\/modpathol.2013.186","journal-title":"Mod Pathol"},{"key":"4723_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.21873\/anticanres.13145","volume":"39","author":"M Sideris","year":"2019","unstructured":"Sideris M, Emin EI, Abdullah Z et al (2019) The Role of KRAS in Endometrial Cancer: A Mini-Review. Anticancer Res 39:533\u2013539. https:\/\/doi.org\/10.21873\/anticanres.13145","journal-title":"Anticancer Res"},{"key":"4723_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41392-021-00780-4","volume":"6","author":"L Huang","year":"2021","unstructured":"Huang L, Guo Z, Wang F et al (2021) KRAS mutation: from undruggable to druggable in cancer. Signal Transduct Target Therapy 6:386. https:\/\/doi.org\/10.1038\/s41392-021-00780-4","journal-title":"Signal Transduct Target Therapy"},{"key":"4723_CR5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/his.12895","volume":"68","author":"M McFarland","year":"2016","unstructured":"McFarland M, Quick CM, McCluggage WG (2016) Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas. Histopathology 68:1013\u20131020. https:\/\/doi.org\/10.1111\/his.12895","journal-title":"Histopathology"},{"key":"4723_CR6","unstructured":"WHO Classification of Tumours Editorial Board (2020) Female genital tumours, WHO classification of tumours, 5th edn. International Agency for Research on Cancer (IARC)"},{"key":"4723_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/pas.0000000000001193","volume":"43","author":"DL Kolin","year":"2019","unstructured":"Kolin DL, Costigan DC, Dong F et al (2019) A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the Endometrium. Am J Surg Pathol 43:389\u2013398. https:\/\/doi.org\/10.1097\/pas.0000000000001193","journal-title":"Am J Surg Pathol"},{"key":"4723_CR8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/pas.0000000000001612","volume":"45","author":"J Pors","year":"2021","unstructured":"Pors J, Segura S, Chiu DS et al (2021) Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract. Am J Surg Pathol 45:498\u2013506. https:\/\/doi.org\/10.1097\/pas.0000000000001612","journal-title":"Am J Surg Pathol"},{"key":"4723_CR9","doi-asserted-by":"publisher","first-page":"15727","DOI":"10.1007\/s00432-023-05306-9","volume":"149","author":"CE Brambs","year":"2023","unstructured":"Brambs CE, Horn L-C, Hiller R et al (2023) Mesonephric-like adenocarcinoma of the female genital tract: possible role of KRAS-targeted treatment\u2014detailed molecular analysis of a case series and review of the literature for targetable somatic KRAS-mutations. J Cancer Res Clin Oncol 149:15727\u201315736. https:\/\/doi.org\/10.1007\/s00432-023-05306-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"4723_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.21873\/cgp.20338","volume":"19","author":"HG KIM","year":"2022","unstructured":"KIM HG, KIM H, YEO, M.-K. et al (2022) Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Analyses of Clinicopathological, Molecular, and Prognostic Characteristics With Retrospective Review of 237 Endometrial Carcinoma Cases. Cancer Genomics - Proteom 19:526\u2013539. https:\/\/doi.org\/10.21873\/cgp.20338","journal-title":"Cancer Genomics - Proteom"},{"key":"4723_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/pas.0000000000001401","volume":"44","author":"ED Euscher","year":"2020","unstructured":"Euscher ED, Bassett R, Duose DY et al (2020) Mesonephric-like Carcinoma of the Endometrium: A Subset of Endometrial Carcinoma With an Aggressive Behavior. Am J Surg Pathol 44:429\u2013443. https:\/\/doi.org\/10.1097\/pas.0000000000001401","journal-title":"Am J Surg Pathol"},{"key":"4723_CR12","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/pas.0000000000001873","volume":"46","author":"AM Mills","year":"2022","unstructured":"Mills AM, Jenkins TM, Howitt BE et al (2022) Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive Entity. Am J Surg Pathol 46:921\u2013932. https:\/\/doi.org\/10.1097\/pas.0000000000001873","journal-title":"Am J Surg Pathol"},{"key":"4723_CR13","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1097\/pas.0000000000001142","volume":"42","author":"J Pors","year":"2018","unstructured":"Pors J, Cheng A, Leo JM et al (2018) A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract. Am J Surg Pathol 42:1596\u20131606. https:\/\/doi.org\/10.1097\/pas.0000000000001142","journal-title":"Am J Surg Pathol"},{"key":"4723_CR14","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3390\/biomedicines11082269","volume":"11","author":"H-H Koh","year":"2023","unstructured":"Koh H-H, Park E, Kim H-S (2023) Mesonephric-like Adenocarcinoma of the Uterine Corpus: Genomic and Immunohistochemical Profiling with Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution. Biomedicines 11:2269. https:\/\/doi.org\/10.3390\/biomedicines11082269","journal-title":"Biomedicines"},{"key":"4723_CR15","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41379-021-00799-6","volume":"34","author":"EM da Silva","year":"2021","unstructured":"da Silva EM, Fix DJ, Sebastiao APM et al (2021) Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases. Mod Pathol 34:1570\u20131587. https:\/\/doi.org\/10.1038\/s41379-021-00799-6","journal-title":"Mod Pathol"},{"key":"4723_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/igc.0000000000001168","volume":"28","author":"CL Jackson","year":"2018","unstructured":"Jackson CL, Hang S, Hansen K et al (2018) Endometrial Adenocarcinomas With Significant Mucinous Differentiation. Int J Gynecol Cancer 28:241\u2013247. https:\/\/doi.org\/10.1097\/igc.0000000000001168","journal-title":"Int J Gynecol Cancer"},{"key":"4723_CR17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1136\/jclinpath-2011-200320","volume":"65","author":"JD Naik","year":"2012","unstructured":"Naik JD, Seligmann J, Perren TJ (2012) Mucinous tumours of the ovary. J Clin Pathol 65:580\u2013584. https:\/\/doi.org\/10.1136\/jclinpath-2011-200320","journal-title":"J Clin Pathol"},{"key":"4723_CR18","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.21873\/anticanres.12521","volume":"38","author":"J-Y Sung","year":"2018","unstructured":"Sung J-Y, Jung YY, Kim H-S (2018) Clinicopathological Characteristics and KRAS Mutation Status of Endometrial Mucinous Metaplasia and Carcinoma. Anticancer Res 38:2779\u20132786. https:\/\/doi.org\/10.21873\/anticanres.12521","journal-title":"Anticancer Res"},{"key":"4723_CR19","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1038\/modpathol.2015.142","volume":"29","author":"A Malpica","year":"2016","unstructured":"Malpica A (2016) How to approach the many faces of endometrioid carcinoma. Mod Pathol 29:S29\u2013S44. https:\/\/doi.org\/10.1038\/modpathol.2015.142","journal-title":"Mod Pathol"},{"key":"4723_CR20","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.humpath.2015.03.010","volume":"46","author":"W Hong","year":"2015","unstructured":"Hong W, Abi-Raad R, Alomari AK et al (2015) Diagnostic application of KRAS mutation testing in uterine microglandular proliferations. Hum Pathol 46:1000\u20131005. https:\/\/doi.org\/10.1016\/j.humpath.2015.03.010","journal-title":"Hum Pathol"},{"key":"4723_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/path.856","volume":"194","author":"M Saegusa","year":"2001","unstructured":"Saegusa M, Okayasu I (2001) Frequent nuclear \u03b2-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J Pathol 194:59\u201367. https:\/\/doi.org\/10.1002\/path.856","journal-title":"J Pathol"},{"key":"4723_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/pgp.0000000000000747","volume":"40","author":"VT Meljen","year":"2021","unstructured":"Meljen VT, Mittenzwei R, Wong J et al (2021) Endometrial Adenocarcinomas With No Specific Molecular Profile: Morphologic Features and Molecular Alterations of Copy-number Low Tumors. Int J Gynecol Pathol 40:587\u2013596. https:\/\/doi.org\/10.1097\/pgp.0000000000000747","journal-title":"Int J Gynecol Pathol"},{"key":"4723_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-026-16370-y","author":"W-Q Li","year":"2026","unstructured":"Li W-Q, Wu H-X, Li H-B et al (2026) Molecular characteristics and clinicopathology of CTNNB1-mutated endometrial cancer: Implications for fertility-sparing management in young women. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-026-16370-y","journal-title":"BMC Cancer"},{"key":"4723_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ygyno.2024.10.026","volume":"191","author":"KA Kilowski","year":"2024","unstructured":"Kilowski KA, Dietrich MF, Xiu J et al (2024) KRAS mutations in endometrial cancers: Possible prognostic and treatment implications. Gynecol Oncol 191:299\u2013306. https:\/\/doi.org\/10.1016\/j.ygyno.2024.10.026","journal-title":"Gynecol Oncol"},{"key":"4723_CR25","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.3802\/jgo.2021.32.e79","volume":"32","author":"E Kaneko","year":"2021","unstructured":"Kaneko E, Sato N, Sugawara T et al (2021) MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas. J Gynecol Oncol 32:e79. https:\/\/doi.org\/10.3802\/jgo.2021.32.e79","journal-title":"J Gynecol Oncol"},{"key":"4723_CR26","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00432-019-03123-7","volume":"146","author":"L-C Horn","year":"2020","unstructured":"Horn L-C, H\u00f6hn AK, Kr\u00fccken I et al (2020) Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma. J Cancer Res Clin Oncol 146:971\u2013983. https:\/\/doi.org\/10.1007\/s00432-019-03123-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"4723_CR27","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s10555-020-09915-5","volume":"39","author":"J Timar","year":"2020","unstructured":"Timar J, Kashofer K (2020) Molecular epidemiology and diagnostics of KRAS mutations in human cancer. Cancer Metastasis Rev 39:1029\u20131038. https:\/\/doi.org\/10.1007\/s10555-020-09915-5","journal-title":"Cancer Metastasis Rev"},{"key":"4723_CR28","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41401-023-01194-4","volume":"45","author":"Y Chen","year":"2024","unstructured":"Chen Y, Liu Q-p, Xie H et al (2024) From bench to bedside: current development and emerging trend of KRAS-targeted therapy. Acta Pharmacol Sin 45:686\u2013703. https:\/\/doi.org\/10.1038\/s41401-023-01194-4","journal-title":"Acta Pharmacol Sin"},{"key":"4723_CR29","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41591-024-02903-0","volume":"30","author":"A Singhal","year":"2024","unstructured":"Singhal A, Li BT, O\u2019Reilly EM (2024) Targeting KRAS in cancer. Nat Med 30:969\u2013983. https:\/\/doi.org\/10.1038\/s41591-024-02903-0","journal-title":"Nat Med"},{"key":"4723_CR30","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1200\/jco-25-00112","volume":"43","author":"SN Banerjee","year":"2025","unstructured":"Banerjee SN, Van Nieuwenhuysen E, Aghajanian C et al (2025) Efficacy and Safety of Avutometinib\u2009\u00b1\u2009Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60\/GOG-3052\/RAMP 201. J Clin Oncol 43:2782\u20132792. https:\/\/doi.org\/10.1200\/jco-25-00112","journal-title":"J Clin Oncol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04723-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04723-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04723-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:10:57Z","timestamp":1789981857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04723-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":30,"alternative-id":["4723"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04723-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"21 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Ethics Committee of Tianjin Central Hospital of Obstetrics and Gynecology, China.","order":1,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors disclose that they have no significant relationships with or financial interests in any commercial companies pertaining to this article.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data that support the findings of this study are available from the corresponding author, upon reasonable request.","order":3,"name":"Ethics","label":"Data access statement","group":{"name":"EthicsHeading","label":"Declarations"}}]}}